SYS-CON MEDIA Authors: Liz McMillan, Elizabeth White, Ed Featherston, Kevin Benedict, Adrian Bridgwater

News Feed Item

Florida Institute and Dawson James Securities Complete Integene International Holdings Financing

The Florida Institute for the Commercialization of Public Research (Florida Institute) announced today that it has finalized a funding agreement with Integene International Holdings (Integene), a vascular biotechnology company that has developed platform technology for ischemia and associated complications. The Institute supports new company creation based on publicly-funded research across the state, and bridges early funding gaps for companies spinning out of universities and research institutions. In order to qualify for Florida Institute funding, companies must raise matching private investment capital.

In December 2013, the Florida Institute and Dawson James Securities, Inc. (“Dawson James”, Member FINRA/SPIC) announced an alliance to augment early investment in emerging growth innovation companies. Companies undergo a thorough review and vetting process led by the Florida Institute, who provides up to $300,000 in funding to qualified companies. Through the partnership, Dawson James leverages its vast retail investor network to provide the required matching investment. In this case, Dawson James was able to raise more funding than what was required to match Florida Institute funds.

Integene was founded to capitalize on patented biotechnology created to optimize gene and stem cell treatments for cardiovascular disease. The company’s founder, Dr. Keith Webster and his team, in association with the University of Miami, have developed procedures for targeting and regulating human growth factor genes within host tissues, and bio-engineering stem cells to provide optimized therapies for ischemia related disease.

According to Dr. Webster, “The fundraising support provided by Dawson James enabled us to rapidly and efficiently raise the required matching funds to qualify for funds provided by the Florida Institute. These funds will be used to advance the clinical testing of treatments for major life-threatening diseases, initially a condition known as critical limb ischemia for which limb amputation may be the only option for many patients and eventually multiple other cardiovascular indications, diabetic retinopathy and solid tumors.”

“Dawson James Securities has been assisting emerging growth companies since 2004, and is interested in identifying and supporting quality new companies spinning out of Florida’s research institutions,” said Robert Keyser, Jr., Dawson James CEO. “As a full-service boutique investment bank, we are pleased to leverage our broad investor placement capabilities to support the growth of promising Florida companies.”

“We formed this alliance to coordinate company financing from angel investors, venture capitalists, private equity and public markets and to expand Florida’s innovation platform and investor base,” said Jamie Grooms, CEO of the Institute. “The Integene financing represents the first transaction resulting from this alliance, and we will continue to work with Dawson James to support the next generation of great Florida companies.”

About the Florida Institute

Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. Over 100 new company projects have been identified across the state, and the Institute deploys company building and funding programs to promising Florida startups. Thirty-two companies have been funded since the program’s inception.

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SPIC, is a full service investment bank headquartered in Boca Raton, FL. Individuals with interest in investment in emerging growth companies can contact an appropriate Dawson James representative at 561-391-5555.

About Integene International Holdings

Integene International Holdings is a biotech company that has developed a comprehensive treatment for cardiovascular ischemic disease using combinations of proprietary gene and stem cell procedures. Integene technology is based on more than 20 years of NIH-supported pre-clinical development and is currently initiating Phase I/II clinical trials for the treatment of peripheral artery disease (PAD) using these procedures.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
ScriptRock has been included in the list of "Cool Vendors" in the "Cool Vendors in DevOps 2015" report by Gartner, Inc.* ScriptRock provides visibility into the configuration state of an organization's IT environments, enabling the continuous delivery of mission critical services. For enterprises where downtime is not an option, ScriptRock's system-wide overwatch offers the assurance that misconfigurations and anomalies are caught before they affect the business. By satisfying this fundamental ...
“We are a managed services company. We have taken the key aspects of the cloud and the purposed data center and merged the two together and launched the Purposed Cloud about 18–24 months ago," explained Chetan Patwardhan, CEO of Stratogent, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today Arista Networks will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place June 9-11, 2015, at the Javits Center in New York City, NY. Arista Networks was founded to deliver software-driven cloud networking solutions for large data center and computing environments. Arista’s award-winning 10/40/100GbE switches redefine scalability, robustness, and price-performance, with over 3,000 customers and more than three million cloud networking ports depl...
"Blue Box has been around for 10-11 years, and last year we launched Blue Box Cloud. We like the term 'Private Cloud as a Service' because we think that embodies what we are launching as a product - it's a managed hosted private cloud," explained Giles Frith, Vice President of Customer Operations at Blue Box, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The DevOps Institute (DOI) launched on Monday with the mission of serving as the premier source for aligning industry standard quality DevOps training and examination services for enterprise IT. The Institute is led by a Board of Regents who will oversee DOI’s offerings in an effort to codify and promote DevOps’ best practices and standards that enable enterprise IT to deliver more value faster to their customers. The initial Board of Regents includes Gene Kim, Lori MacVittie, Sanjeev Sharma, ...
Puppet Labs on Wednesday released the DevOps Salary Report, based on salary data gathered from Puppet Labs' industry-recognized State of DevOps Report. The data confirms that market demand for DevOps skills is growing, and that DevOps engineers are among the highest paid IT practitioners today. That's because IT organizations today are grappling with how to be more agile and responsive to the business, while maintaining the stability of their infrastructure. DevOps practices, such as continuous ...
@ThingsExpo has been named the Top 5 Most Influential M2M Brand by Onalytica in the ‘Machine to Machine: Top 100 Influencers and Brands.' Onalytica analyzed the online debate on M2M by looking at over 85,000 tweets to provide the most influential individuals and brands that drive the discussion. According to Onalytica the "analysis showed a very engaged community with a lot of interactive tweets. The M2M discussion seems to be more fragmented and driven by some of the major brands present in the...
In a world of ever-accelerating business cycles and fast-changing client expectations, the cloud increasingly serves as a growth engine and a path to new business models. Dynamic clouds enable businesses to continuously reinvent themselves, adapting their business processes, their service and software delivery and their operations to achieve speed-to-market and quick response to customer feedback. As the cloud evolves, the industry has multiple competing cloud technologies, offering on-premises ...
DevOps approaches within “Unicorns” vary significantly from the reality of DevOps in the enterprise. Most enterprises manage portfolios of heterogeneous applications that are increasingly interconnected, delivered by global teams, at various stages of technology maturity, and are often encumbered by additional compliance and governance obligations. In his session at DevOps Summit, Dalibor Siroky, Director and co-founder at Plutora, will discuss the emerging and evolving experiences of Agile, Co...
Artifactory binary repository management system. As one of the most widely used binary repositories and the only repository that offers a high availability clustered solution, the integration with Artifactory helps customers easily adopt CA Release Automation to optimize their entire software development lifecycle. “Artifactory is a standard maker at the continuous-integration domain and provides the user a powerful repository experience with the freedom to choose his own tools set and ecosyste...
Zerto has announced the general availability of Zerto Virtual Replication 4.0 (ZVR 4.0). The company’s enterprise-class business continuity/disaster recovery (BC/DR) software is the first to protect, replicate, and migrate data between VMware vSphere and Microsoft Hyper-V hypervisors, as well as across private, hybrid and public cloud environments including Amazon Web Services (AWS). ZVR 4.0 also allows channel partners and cloud service providers to expand their offerings to grow revenues by pr...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo in Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading in...
@ThingsExpo has been named the Top 5 Most Influential Internet of Things Brand by Onalytica in the ‘The Internet of Things Landscape 2015: Top 100 Individuals and Brands.' Onalytica analyzed Twitter conversations around the #IoT debate to uncover the most influential brands and individuals driving the conversation. Onalytica captured data from 56,224 users. The PageRank based methodology they use to extract influencers on a particular topic (tweets mentioning #InternetofThings or #IoT in this ...
While Docker continues to be the darling of startups, enterprises and IT innovators around the world, networking continues to be a real mess. Indeed, managing the interaction between Docker containers and networks has always been fraught with complications. Without automation in networking, the vision of running Docker at scale and letting IT run the same apps unchanged on the laptop and in the data center or for any cloud cannot be realized.
DevOps Summit, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developmen...